Companies: 10,795·Total market cap: $144.5T
Obalon Therapeutics, Inc.

Obalon Therapeutics, Inc.

OBLNNASDAQHealthcare
$3.05
$-0.19(-5.86%)
Market Cap$5472310
P/E Ratio
52W High$4.8
52W Low$2.948
Overview

Obalon Therapeutics, Inc. (OBLN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · OBLN · as of Mar 18, 2026

Latest filing snapshot

18
+0+0.00%vs prior year

Obalon Therapeutics, Inc. (OBLN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
18
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
$17.8K
Net Income / Employee
$-582.1K
Market Cap
$5M

OBLN Employee Count

2024 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-1818+0+0.00%
2025-04-0418

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Medical - Devices
#SymbolCompanyEmployees
#1
Invitae Corporation
NVTA
Invitae Corporation
1,700
#2
LumiraDx Limited
LMDX
LumiraDx Limited
1,210
#3
Greenbrook TMS Inc.
GBNH
Greenbrook TMS Inc.
492
#4
Xylo Technologies Ltd.
MDGS
Xylo Technologies Ltd.
38
#5
Obalon Therapeutics, Inc.
OBLN
Obalon Therapeutics, Inc.YOU
18
#6
Fresh Tracks Therapeutics, Inc.
FRTX
Fresh Tracks Therapeutics, Inc.
4
#7
Holdco Nuvo Group D.G Ltd. Ordinary Shares
NUVO
Holdco Nuvo Group D.G Ltd. Ordinary Shares
N/A
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · OBLN peer comparison

About OBLN employees

OBLN Employees · Headcount

Obalon Therapeutics, Inc. (OBLN) employee data is sourced from the annual SEC 10-K filing. As of 2025, Obalon Therapeutics, Inc. had 18 full-time employees globally. Full-time employees only. Global consolidated headcount.

Obalon Therapeutics, Inc. employs 18 full-time employees as of the latest filing within the Medical - Devices industry. Revenue per employee stands at $17,762, reflecting the company's operational efficiency.

Obalon Therapeutics, Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Obalon Therapeutics, Inc.'s revenue per employee of $17,762 positions it among the notable performers in the Medical - Devices sector for operational efficiency.

Frequently Asked Questions

OBLN Employees · 5 questions

As of the latest SEC 10-K filing (2025), Obalon Therapeutics, Inc. had 18 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Obalon Therapeutics, Inc. employee counthow many employees does Obalon Therapeutics, Inc. haveOBLN total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-18